GIS General Mills
Impairments hide a still-cash-generative brand portfolio; value depends on margins recovering to about 15% despite heavy debt.
The story
General Mills is a mature packaged-food franchise (Cheerios, Pillsbury, Blue Buffalo) losing volume to private label, GLP-1 driven consumption shifts and value-seeking consumers, and it is reinvesting in price to defend share. The negative TTM operating margin reflects non-cash impairments and restructuring charges layered on a real but smaller decline in underlying profitability, not a collapse of the brands' cash generation. The company is in late maturity, and the main valuation question is where margins settle, not growth.
Growth, terminal growth, sales-to-capital, beta and failure risk are unchanged because the core story still holds: slow shrinkage, low reinvestment needs and staples-like risk. The target margin moves slightly from 15.5% to 15% because price investments have structurally reduced adjusted profitability. Margin_years moves from 2 to 3 (a material change) because the reported trough is now deeper, near -0.6% including impairments, so normalization will take longer. Net debt of about $13B makes value highly sensitive to the margin path.
Value drivers
| Revenue growth (Y1) | -3.0% |
| Terminal growth | 1.0% |
| Forecast horizon | 5y |
| Target operating margin | 15.0% |
| Years to target margin | 3 |
| Sales-to-capital | 1.20 |
| Beta | 0.65 |
| Failure probability | 2.0% |
| Cost of capital (WACC) | 6.9% |
| Terminal WACC | 7.2% |
Valuation bridge
| PV of explicit FCFF | 5.24B |
| PV of terminal value | 16.98B |
| Equity value | 8.94B |
| ÷ shares → per share | $16.72 |
Projected free cash flow to the firm
| Yr | Revenue | Growth | Margin | NOPAT | Reinvest | FCFF | PV |
|---|---|---|---|---|---|---|---|
| 1 | 17.75B | -3.0% | 4.6% | 530.23M | 0 | 530.23M | 496.03M |
| 2 | 17.39B | -2.0% | 9.8% | 1.11B | 0 | 1.11B | 969.43M |
| 3 | 17.22B | -1.0% | 15.0% | 1.68B | 0 | 1.68B | 1.37B |
| 4 | 17.22B | 0.0% | 15.0% | 1.68B | 0 | 1.68B | 1.29B |
| 5 | 17.39B | 1.0% | 15.0% | 1.70B | 143.49M | 1.55B | 1.11B |
Key risks
- Volume erosion from GLP-1 adoption and private label is faster than expected, so 15% margins are not recoverable
- Further impairments signal that acquired brands (Blue Buffalo, pet treats) are worth structurally less
- High leverage, at about $13B net debt, could pressure the dividend or the credit rating if cash flow drops
Catalysts
- Clean quarters without impairments that show adjusted operating margin stabilizing near 15%
- Portfolio pruning or deleveraging from divestiture proceeds